20.03.2024 16:52 | CREO | Holding(s) in Company | RNS |
19.03.2024 07:00 | CREO | Welsh Labour Leader visits Creo’s facilities | Reach |
13.03.2024 15:05 | CREO | Holding(s) in Company | RNS |
11.03.2024 14:00 | CREO | LTIP Awards | RNS |
06.03.2024 16:35 | CREO | Holding(s) in Company | RNS |
01.03.2024 13:34 | CREO, MBO, ECO | EARNINGS AND TRADING: Dar Global celebrates "outstanding" year | Alliance |
01.03.2024 07:00 | CREO | Microwave Lung Ablation Update | Reach |
07.02.2024 10:54 | CREO | Creo Medical makes "considerable strides" toward 2025 break-even goal | Alliance |
07.02.2024 09:12 | CREO | Trading Update - Replacement | RNS |
07.02.2024 07:00 | CREO | Trading Update | RNS |
05.02.2024 12:11 | CREO | IN BRIEF: Creo Medical partners with Khalifa University in Abu Dhabi | Alliance |
05.02.2024 07:00 | CREO | Strategic Collaboration with Khalifa University | Reach |
31.01.2024 18:15 | OMG, CHAR, SYN | TRADING UPDATES: Creo unveils product in APAC; Unilever hires director | Alliance |
31.01.2024 07:00 | CREO | Speedboat® UltraSlim roll-out reaches Asia Pacific | Reach |
22.01.2024 07:00 | CREO | Award of Shares under Share Incentive Plan | RNS |
10.01.2024 12:32 | CREO | Creo Medical's Speedboat UlstraSlim device used in Latin America | Alliance |
10.01.2024 07:00 | CREO | First use of Speedboat® UltraSlim in Latin America | Reach |
15.12.2023 14:17 | CREO | IN BRIEF: Creo Medical's SpeedBoat UltraSlim successfully used in US | Alliance |
15.12.2023 07:00 | CREO | First use of Speedboat® UltraSlim in the USA | Reach |
13.12.2023 21:14 | ASIA, MACF, CREO | TRADING UPDATES: Good Energy says ZapMap expands into mainland Europe | Alliance |
13.12.2023 07:00 | CREO | First European Speedboat® UltraSlim procedure | Reach |
07.11.2023 07:00 | CREO | Capital Markets Day | RNS |
01.11.2023 07:00 | CREO | Speedboat® UltraSlim: US FDA Clearance | RNS |
25.10.2023 13:41 | CREO | Creo Medical says EU launch of SpeedBoat UltraSlim device accelerated | Alliance |
25.10.2023 07:00 | CREO | SB UltraSlim: EU launch accelerated by 18 months | RNS |
16.10.2023 10:16 | CREO | Change of Nominated Adviser and Joint Broker | RNS |
12.10.2023 07:00 | CREO | Investor Presentation | Reach |
12.09.2023 11:47 | CREO | Creo Medical hails Speedboat Inject device as interim loss narrows | Alliance |
12.09.2023 07:00 | CREO | Half-year Report | RNS |
05.09.2023 15:47 | SMS, RGL, TPFG | UK earnings, trading statements calendar - next 7 days | Alliance |
05.09.2023 07:00 | CREO | Notice of Results | RNS |
16.08.2023 12:11 | CREO | Creo Medical says NHS hospital uptake for service "fastest time" ever | Alliance |
16.08.2023 07:00 | CREO | Royal Oldham SSD service update | Reach |
03.08.2023 10:48 | CREO | Creo Medical expects "considerable strides" as half year revenue rises | Alliance |
03.08.2023 07:00 | CREO | Half Year Trading Update | RNS |
28.07.2023 07:00 | CREO | Total Voting Rights | RNS |
24.07.2023 10:40 | CREO | Award of Shares under Share Incentive Plan | RNS |
06.07.2023 11:33 | CREO | Issue of Equity and TVR | RNS |
27.06.2023 20:08 | GRL, MPL, AGT | TRADING UPDATES: Creo Medical sees growing demand for products | Alliance |
27.06.2023 13:15 | CREO | Result of AGM | RNS |
27.06.2023 07:00 | CREO | AGM Statement & Directorate Succession Planning | RNS |
26.06.2023 10:51 | CREO | Creo Medical reports first use of Speedboat Inject procedure in Europe | Alliance |
26.06.2023 10:06 | PREM, MSYS, CREO | AIM WINNERS & LOSERS: Premier African plunges on force majeure notice | Alliance |
26.06.2023 07:00 | CREO | First upper GI Speedboat procedure in Europe | RNS |
22.06.2023 07:00 | CREO | Appointment of Marco Scarci | Reach |
20.06.2023 15:44 | TRIN, SUN, SCE | UK shareholder meetings calendar - next 7 days | Alliance |
19.06.2023 10:48 | CREO | IN BRIEF: Creo Medical Speedboat Inject cleared for use in Europe | Alliance |
19.06.2023 07:00 | CREO | Speedboat Inject upper GI clearance in Europe | RNS |
01.06.2023 12:01 | CREO | UK NICE selects Creo Medical's Speedboat Inject product for assessment | Alliance |
01.06.2023 07:00 | CREO | Speedboat™ Inject selected by NICE for assessment | RNS |
26.05.2023 07:00 | CREO | Posting of Annual Report and Notice of AGM | RNS |
23.05.2023 09:53 | CREO | Creo Medical hails first in-human milestone for lung tumour device | Alliance |
23.05.2023 07:00 | CREO | First in-human milestone for MicroBlate™ Flex | RNS |
17.05.2023 14:40 | CREO | IN BRIEF: Creo endoscopy devices picked by NHS England hospital | Alliance |
17.05.2023 07:00 | CREO | Royal Oldham Hospital Agreement | Reach |
15.05.2023 07:00 | CREO | Attendance at Digestive Disease Week | Reach |
26.04.2023 14:43 | TPOU, MGCI, CREO | EARNINGS SUMMARY: Third Point Investors NAV per share drops by quarter | Alliance |
26.04.2023 07:00 | CREO | Final Results | RNS |
14.04.2023 17:53 | CREO | IN BRIEF: Creo Medical completes earn-out for Albyn acquisition | Alliance |
14.04.2023 07:00 | CREO | Albyn Medical earn out update | RNS |
31.03.2023 10:45 | CREO | Total Voting Rights | RNS |
31.03.2023 07:00 | CREO | MicroBlate™ Flex clinical study | Reach |
13.03.2023 18:13 | CREO | Director/PDMR and PCA Share Dealings | RNS |
13.03.2023 07:00 | CREO | Holding(s) in Company | RNS |
08.03.2023 10:25 | CREO | Result of GM | RNS |
06.03.2023 11:05 | CREO | Second Price Monitoring Extn | RNS |
06.03.2023 11:00 | CREO | Price Monitoring Extension | RNS |
01.03.2023 15:57 | JEL, GWI, CREO | UK shareholder meetings calendar - next 7 days | Alliance |
21.02.2023 10:29 | CREO | Holding(s) in Company | RNS |
17.02.2023 14:07 | CREO | IN BRIEF: Creo Medical launches open offer to raise GBP5.2 million | Alliance |
17.02.2023 14:05 | CREO | Second Price Monitoring Extn | RNS |
17.02.2023 14:00 | CREO | Price Monitoring Extension | RNS |
17.02.2023 12:10 | CREO | Launch of Open Offer and Posting of Circular | RNS |
16.02.2023 21:35 | MIG3, MAV4, CEG | TRADING UPDATES: Heavitree profit soars; Riverstone net assets rise | Alliance |
16.02.2023 18:04 | CREO | Result of Placing and Subscription | RNS |